458 -Ⅱ 1 2 2 2 2 2 1. 300193 2. -Ⅱ 6 -Ⅱ BL-420 S NO LDH CK T ST NO LDH CK P< 0.01 -Ⅱ P<0.05 T ST NO LDH CK P<0.01 -Ⅱ -Ⅱ R969.4 A DOI:10.16343/j.cnki.issn.2095-512x.2017.05.016 2095-512X 2017 05-0458-05 PHARMACODYNAMIC STUDY OF MONGOLIAN MEDICINE JIRUHEN NEW NO.2 ON THE MYOCARDIAL ISCHEMIA IN RATS WU Yu-xiao LI Li SA Ren Gaowa et al. Tianjin University of Traditional Chinese Medicine Tianjin 300193 China Abstract Objective To explore the rapeutic effect of Mongolian medicine Jiruhen new No.2 new No. 2 on myocardial ischemia. Methods Using comprehensive methods such as feeding fatigue establish " qixu" model of myocardial ischemia model in rats.rats were randomly divided into normal group model group control group new No.2 high medium low dosage group each group was administered by corresponding drug and examined ECG and serum NO LDH CK.Results After modeling compared with the normal group there are significant ischemic change in ECG and serum NO LDH CK P < 0.01. After treatment with new No. 2 compared with the model group No. 2 significantly improve the ischemic change in ECG and serum NO LDH CK P < 0.05 or P < 0.01. Conclusion 2017-04-04 2017-05-04 NJZZ11115 2014MS0844 1982-2013 E-mail changbai2010@ aliyun.com 010059
2017 10 39 5 459 Middle dose of Mongolian Medicine Jiruhenxin-new No.2 has better effects on myocardial ischemia. Key words mongolian medicine jiruhenxin-new No.2 myocardial ischemia model pharmacodynamie 1 7 8 -Ⅱ 1.2 2 16 BL-420S 9~ 30s 1mim 2min 12 coronary heart diease CHD 3000r /min 15min 3~ 6 13~ CK LDH NO 15 -Ⅱ 1.3 SPSS 17.0 x±s 珋 P<0.05 -Ⅱ 2 1 1.1 4wk SPF Wistar SCXZ 2002-0001 60 200 ± 20 g -Ⅱ 2.2 10 4wk T ST NO LDH CK P < 1.5 1.5 1 2.5 1.5 1 0.01 6wk -Ⅱ 60mg /ml d 10min 5wk 0.2g /kg 2.1 P < 0.05 -Ⅱ -Ⅱ 1g /kg - P<0.05 - Ⅱ 0.5g /kg -ⅡⅡ 0.25g /kg 6wk 2 /d 1 ~ 6 1 ~ 6 1 Tab.1 -Ⅱ / n = 10 x±s 珋 Effects of Jiruhen-new No.2 on heart rate times /min of ECG in rats n = 10 珋 x±s 485.0±13.7 467.3±15.3 495.6±10.7 482.5±17.5 276.2±9.9 262.8±7.4 473.4±15.8 288.4±6.9 362.5±12.9 -Ⅱ 460.2±18.5 269.2±8.2 375.1±10.6 -Ⅱ 490.2±11.4 280.8±7.1 422.2±8.6 -Ⅱ 456.0±22.6 271.6±5.6 399.0±9.9 P<0.01 P<0.01
460 2 -Ⅱ T mv n = 10 x±s 珋 Tab.1 Effects of Jiruhen-new No.2 on T wave mv of ECG in rats n = 10 珋 x±s 0.07±0.016 0.07±0.018 0.08±0.019 0.08±0.020 0.32±0.151 0.34±0.14 0.07±0.017 0.35±0.133 0.26±0.081 -Ⅱ 0.06±0.021 0.36±0.132 0.16±0.072 -Ⅱ 0.08±0.017 0.33±0.141 0.13±0.051 -Ⅱ 0.08±0.020 0.34±0.138 0.21±0.067 P<0.01 P<0.01 3 Tab.3 -Ⅱ ST mv n = 10 x±s 珋 Effects of Jiruhen-new No.2 on ST segment mv of ECG in rats n = 10 珋 x±s 0.178±0.01 0.191±0.017 0.179±0.019 0.190±0.018 0.318±0.015 0.339±0.019 0.188±0.025 0.294±0.031 0.252±0.031 -Ⅱ 0.196±0.013 0.323±0.029 0.228±0.027 -Ⅱ 0.181±0.023 0.327±0.022 0.206±0.020 -Ⅱ 0.187±0.016 0.303±0.022 0.231±0.017 P<0.01 P<0.01 4 Tab.4 -Ⅱ NO μmol /L n = 10 x±s 珋 Effects of Jiruhen-new No.2 on serum NO concentrations μmol /L in rats n = 10 x±s 珋 70.58±12.71 75.29±6.68 41.20±13.04 43.53±10.76 43.53±12.46 61.76±19.06 -Ⅱ 42.95±5.59 65.88±18.14 -Ⅱ 42.94±11.45 84.70±10.07 -Ⅱ 41.77±7.05 65.88±9.11 P<0.01 P<0.01 5 Tab.5 -Ⅱ LDH U /L n = 10 x±s 珋 Effects of Jiruhen-new No.2 on serum LDH concentrations U /L in rats n = 10 x±s 珋 557.5±71.0 533.8±84.0 2026.08±201.8 2413.9±178.3 1863.1±244.0 1633.7±151.6 -Ⅱ 2119.9±166.9 986.6±196.2 -Ⅱ 2087.06±94.1 916.6±100.1 -Ⅱ 2352.4±108.1 1337.6±114.8 P<0.01 P<0.01 6 Tab.6 -Ⅱ CK U /L n = 10 x±s 珋 Effects of Jiruhen-new No.2 on serum CK concentrations U /L in rats n = 10 x±s 珋 997.1±59.5 975.9±135.3 2661.6±146.4 2839.8±114.1 2765.2±135.4 2202.0±96.9 -Ⅱ 2866.8±77.3 1472.4±84.9 -Ⅱ 2552.2±111.8 1271.4±129.0 -Ⅱ 2682.7±102.5 1990.03±137.5 P<0.01 P<0.01
2017 10 39 5 461 1 Fig.1 ECG of rats in normal group 2 Fig.2 ECG of rats in model group 3 Fig.3 ECG of rats in control group Fig.4 4 -Ⅱ ECG of rats in Jiruhen-new No.2 high dose group Fig.5 5 3 -Ⅱ 6 -Ⅱ ECG of rats in Jiruhen-new No.2 medium dose group Fig.6 ECG of rats in Jiruhen-new No.2 low dose group 18 -Ⅱ 16 17 LDH CK NO T ST 19~ 22 -Ⅱ -Ⅱ -Ⅱ 50 1. M. 1997 90 2. M. 16 CHD 1997 440 3.
462 J. 2016 4 38 898-902 4. S 14. 2010 55-56 atp ldh CK J. 2015 5. M. 30 2 248-250 2004 100-102 15. 6. J. J. 2011 12 35 2014 6 36 527-531 3349-3351 7. results in hemody-namic changes in subjects with blunted J. 2012 8 28 1053-1057 8. M. 2. 2014 78 9 Xie Z Su W Liu S et al. Smooth - muscle bmal 1 participates in blood pres-sure circadian rhythm regulation J.J Clin Invest 2015 125 1 324-336 10 Schillaci G Battista F Settimi L et al. Antihypertensive drug treatment and circadian blood pressure rhythm a review of the role of chronotherapy in hyper - tension J. Curr Pharm Des 2015 21 6 756-772 11. J. 2010 21 J. 2013 2 28 10 2707-2709 219-220 12. J. 2011 26 1 39-40 J. 2015 1 22. 31 27-29 2016 40 2 96-103 16 Chen SY Chan CC Lin YL et al. Fine particulate matter nocturnal blood pressure dipping J. Environ Res 2014 131 7 1-5 17 Soejima Y Hu Q. Hyperbaric oxygen preconditioning attenuates hy-perglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats J.ExpNeurol 2013 4 6 737 18. M 2007 11-22 13. J. 19. / J. 2009 12 3 301-303 20. 21. J. 2011 17 15 265-269 檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪 457 13. ral Radiol Endod 2009 108 3 465-470 J. 2013 29 11 701-703 14. J of naocl in contact with bovine dentine effect of 2014 41 1 72-76 15 Vander sluis LW Vogels MP Verhaagen B et al.study on the influence of refreshment activation cycles and irrigants on mechanical cleaning efficiency during ultrasonic activation of the irrigant J.J Endod 2010 36 4 737-740 16 Goel S Tewari S. Smear layer removal with passive ultrasonic irrigation and the navitip FX a scanning electron microscopic study J.Oral Surg Oral Med Oral Pathol O- 17 Macedo RG Wesselink PR Zaccheo F et al.reaction rate activation Exposure time Concentration and ph J. Int Endod J 2010 43 12 1108-1115 18 Passarinho-neto JG Marchesan MA Ferreira RB et al.in vitro evaluation of endodontic debris removal as obtained by rotary instrumentation coupled with ultrasonic irrigation J.Aust Endod J 2006 32 3 123-128